ORMP ORAMED PHARMACEUTICALS INC.
Nasdaq · SEC CIK 1176309 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $942.2K 2 sales by 2 insiders
- Filings on record
- 116 since 2021-08-06, latest 2026-07-02 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hexter Joshua | COO, CBO | — | $611.4K |
| Gabay Avraham | CFO | — | $330.7K |
| Reznick Yehuda | Dir | — | — |
| Aghion Daniel | Dir | — | — |
| Shapiro Benjamin | Dir | — | — |
| Mayer Arie | Dir | — | — |
| Kidron Miriam | CSO, Dir | — | — |
| KIDRON NADAV | Pres, CEO, Dir | — | — |
Transactions 125
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | ORMP | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $13.89 | -48.8K | 887.7K | -5% | -$677.2K |
| D | 2022-01-05 | 2022-01-03 | ORMP | Silberman David | CFO | A - Grant | — | +19.0K | 69.0K | +38% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | Hexter Joshua | COO, CBO | A - Grant | — | +21.0K | 124.3K | +20% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | Sank Leonard | Dir | A - Grant | — | +6,000 | 6,000 | New | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | Friedman Aviad | Dir | G - Gift | $0.00 | -6,000 | 0 | -100% | $0 |
| D | 2022-01-05 | 2022-01-03 | ORMP | Friedman Aviad | Dir | A - Grant | — | +6,000 | 6,000 | New | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | RAKIN KEVIN | Dir | A - Grant | — | +6,000 | 58.0K | +12% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | Kidron Miriam | CSO, Dir | A - Grant | — | +42.0K | 183.7K | +30% | — |
| 2021-12-30 | 2021-12-28 | ORMP | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $12.98 | -31.7K | 786.5K | -4% | -$411.8K | |
| 2021-12-30 | 2021-12-30 | ORMP | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 766.5K | -3% | — | |
| 2021-12-30 | 2021-12-28 | ORMP | Rabinowitz Michael | Chief Commercial Off | F - Tax | $12.98 | -9,532 | 90.5K | -10% | -$123.7K | |
| 2021-12-17 | 2021-12-16 | ORMP | RAKIN KEVIN | Dir | G - Gift | $0.00 | -5,000 | 52.0K | -9% | $0 | |
| A | 2021-12-07 | 2021-08-31 | ORMP | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +100.0K | 838.2K | +14% | — |
| A | 2021-12-07 | 2021-08-09 | ORMP | KIDRON NADAV | Pres, CEO, Dir, 10% | S - Sale | $20.11 | -220.0K | 738.2K | -23% | -$4.42M |
| 2021-12-07 | 2021-12-03 | ORMP | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 818.2K | -2% | — | |
| 2021-09-20 | 2021-09-16 | ORMP | RAKIN KEVIN | Dir | S - Sale | $20.99 | -21.1K | 57.0K | -27% | -$442.9K | |
| 2021-09-02 | 2021-08-31 | ORMP | RAKIN KEVIN | Dir | A - Grant | — | +10.0K | 78.1K | +15% | — | |
| 2021-09-02 | 2021-08-31 | ORMP | Kidron Miriam | CSO, Dir | A - Grant | — | +66.7K | 141.7K | +89% | — | |
| 2021-09-02 | 2021-08-31 | ORMP | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +100.0K | 748.6K | +15% | — | |
| D | 2021-09-02 | 2021-09-01 | ORMP | Silberman David | CFO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| 2021-09-02 | 2021-08-31 | ORMP | Hexter Joshua | Chief Operating, BO | A - Grant | — | +33.3K | 103.3K | +48% | — | |
| 2021-08-11 | 2021-08-09 | ORMP | KIDRON NADAV | Pres, CEO, Dir, 10% | S - Sale | $20.11 | -220.0K | 648.6K | -25% | -$4.42M | |
| DM | 2021-08-11 | 2021-08-09 | ORMP | RAKIN KEVIN | Dir | F - Tax | $21.09 | -26.1K | 19.1K | -58% | -$550.3K |
| DM | 2021-08-11 | 2021-08-09 | ORMP | RAKIN KEVIN | Dir | M - OptEx | $6.95 | +79.1K | 34.2K | New | +$550.3K |
| D | 2021-08-06 | 2021-08-04 | ORMP | Rabinowitz Michael | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations